But drug will have boxed warning over suicidal ideation.
Celgene continues with focus on autoimmune diseases.
But patents could delay launch for more than a year.
Sales of Humira could peak above $18 billion – CEO
Biotech specialises in autoimmune disorder drugs.
Sales of dermatology drug are already mounting.
Psoriasis drug surges in Q2.